Omalizumab or dupilumab suggested for adults with moderate-to-severe allergic asthma, history of exacerbations requiring oral ...

Patients who take omalizumab prior to starting oral immunotherapy (OIT) may skip much of the latter treatment’s onerous dose escalation process, according to a new study presented at the American ...

Please provide your email address to receive an email when new articles are posted on . Robert A. Wood, MD, FAAAAI, looks back on the first year of omalizumab’s use for food allergy. Patients often ...

When asked about food allergy management, more individuals reported choosing allergen avoidance over oral immunotherapy or ...

The nasal response to a nasal allergen challenge is attenuated by omalizumab treatment. Hanf and colleagues [71] randomized 23 patients with allergic rhinitis (seasonal and/or perennial) to 16 weeks ...